In end-stage renal disease patients, the frequency of CD4+CD57+ T-cells is associated with atherosclerotic changes [41], and in multiple sclerosis, their frequency is associated with disease severity and poorer prognosis [42]. This evidence concerns the gene CD4 and multiple sclerosis.